evolcSign inStart free
Menu

Reagena

Diagnostic tests and laboratory reagents for clinical, biotechnology, pharmaceutical and research organizations

Toivala, FinlandFounded 2012reagena.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-29

About Reagena

Reagena develops, manufactures and sells diagnostic products for infectious diseases, including Hantavirus, tick-borne infections and Lyme disease. Its portfolio includes rapid point-of-care tests, ReaScan rapid tests, EIA tests and staining solutions.

Its products are used by clinical laboratories, diagnostics companies, biotechnology and pharmaceutical industries, environmental and food industries, universities and research institutes. Reagena is based in Toivala, Finland, and was founded in 2012.

Product: Rapid diagnostic tests, EIA tests, staining solutions and liquid-based solutions and reagents for life sciences.

Public tenders won

7 tenders won since 1 Jan 2024 from 4 public buyers in Finland, worth €2.8M as awarded. From EU award notices (TED) that name Reagena by its registry number.

  • 21 Sep 2026 Varsinais-Suomen hyvinvointialue · KTE84/26 Autoimmuuniserologian IF-automaatio · €454k notice
  • 20 Mar 2026 HUS-yhtymä · Virusten pika-Ago-Ab-diagnostiikka · €432k notice
  • 26 Feb 2026 HUS Group · Digital automatic microscope for the special hematology laboratory at HUS Diagnostic Center · €535k notice
  • 17 Oct 2025 HUS-yhtymä / Diagnostiikkakeskus · Laitteisto ja reagenssit biologisten lääkeainemääritysten analysointiin · €710k notice
  • 11 Dec 2024 HUS-yhtymä · Reagenssit BP180 · €160k notice
  • 8 Oct 2024 HUS-yhtymä · Line blot -testikitti paraneoplastisten vasta-aineiden osoitukseen seerumista ja likvorista · €281k notice

Open tenders like these →

Jobs at Reagena

No open positions listed right now.

More biotech & pharma companies

  • ReBio Technologies

    Develops targeted, locally delivered drug conjugates for ocular cancers, starting with uveal melanoma
    Raisio, FinlandBiotech & pharmaFounded 2015
    New on Evolc

  • Replicon Health

    Develops oral drug candidate RH013001 for aging-related degenerative diseases and seeks pharma partners to bring it to market
    Espoo, FinlandBiotech & pharmaFounded 2002
    New on Evolc

  • RNatives

    Develops RNA-based gene-regulating therapies for serious diseases, with research and offices in Kuopio, Finland
    Kuopio, FinlandBiotech & pharmaFounded 2020
    New on Evolc

  • Sartar Therapeutics

    Develops targeted cancer therapies for patients with gastrointestinal stromal tumours and other cancers
    Helsinki, FinlandBiotech & pharmaFounded 2016
    New on Evolc

  • Scaffdex

    Finnish maker of the RegJoint bioresorbable small-joint implant and CellCrown cell culture inserts for clinicians and researchers
    Tampere, FinlandBiotech & pharmaFounded 2006
    New on Evolc

  • SCellex

    Spatial and bulk 3' RNA-seq tools and services for single-cell gene expression research in biotech and life sciences
    Helsinki, FinlandBiotech & pharmaFounded 2018
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cookiebot
  • Google Tag Manager
  • WordPress
  • jQuery
  • nginx